Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer
- PMID: 1699766
- DOI: 10.1159/000463885
Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer
Abstract
The authors calculated the volume of the prostate by transrectal ultrasonography and evaluated prostate-specific antigen (PSA) in 108 patients with benign prostatic disease or with clinically suspected carcinoma and in 35 normal subjects. In each case the PSA value was related to the corresponding gland volume (V), which gives a PSA/V index. 32 patients underwent transurethral resection, 23 underwent open prostatectomy and biopsy was performed in 53. Histological examination revealed benign prostatic hyperplasia in 63, prostatitis in 12 and carcinoma in 33. In normal subjects and in those with benign prostatic diseases, the mean PSA/V index was 0.090 and 0.099, respectively. In patients with prostatic carcinoma the ratio was 1.73. The authors propose that this ratio be used, as an alternative to the absolute value of PSA, to differentiate patients with benign and malignant diseases of the prostate.
Similar articles
-
[Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate].Radiol Med. 1991 Jun;81(6):857-60. Radiol Med. 1991. PMID: 1713333 Italian.
-
Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia: are correlations with prostate specific antigen clinically useful?Prostate Suppl. 1992;4:51-7. doi: 10.1002/pros.2990210508. Prostate Suppl. 1992. PMID: 1374178
-
Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer.Cancer. 1992 Jul 1;70(1 Suppl):211-20. doi: 10.1002/1097-0142(19920701)70:1+<211::aid-cncr2820701307>3.0.co;2-d. Cancer. 1992. PMID: 1376190
-
[Transrectal ultrasonography of the prostate--prolonged finger of the urologist].Lakartidningen. 1992 Nov 4;89(45):3827-31. Lakartidningen. 1992. PMID: 1281251 Review. Swedish. No abstract available.
-
The current role of transrectal ultrasonography in the evaluation of prostate carcinoma.Semin Roentgenol. 1999 Oct;34(4):284-94. doi: 10.1016/s0037-198x(99)80006-6. Semin Roentgenol. 1999. PMID: 10553604 Review. No abstract available.
Cited by
-
Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions.Int Braz J Urol. 2019 Jul-Aug;45(4):713-723. doi: 10.1590/S1677-5538.IBJU.2018.0768. Int Braz J Urol. 2019. PMID: 31136112 Free PMC article.
-
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.Nat Rev Urol. 2009 Jul;6(7):384-91. doi: 10.1038/nrurol.2009.123. Nat Rev Urol. 2009. PMID: 19578355 Free PMC article. Review.
-
History of the discovery and clinical translation of prostate-specific antigen.Asian J Urol. 2014 Oct;1(1):12-14. doi: 10.1016/j.ajur.2014.09.008. Epub 2015 Apr 16. Asian J Urol. 2014. PMID: 29511633 Free PMC article. No abstract available.
-
The value of prostatic specific antigen density in the early diagnosis of prostate cancer.Int Urol Nephrol. 1998;30(3):305-10. doi: 10.1007/BF02550314. Int Urol Nephrol. 1998. PMID: 9696337
-
Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: correlation with removed prostate weight.Int Urol Nephrol. 1996;28(4):517-23. doi: 10.1007/BF02550959. Int Urol Nephrol. 1996. PMID: 9119637
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous